Multiple programs. Multiple billion-dollar markets. And a news pipeline that could deliver weekly catalysts.
| On Behalf of BioNxt Solutions Inc. | | Dear Reader,
Most biotech firms balloon into expensive operations chasing a single unproven therapy. They burn hundreds of millions and spend a decade waiting for approval.
This company runs lean. Patents first. Outsourced trials. A focused pipeline built on reformulating existing drugs.
The story started when an oncologist lost his lab in Ukraine and joined forces with a Canadian entrepreneur.
Together they built a German R&D hub specializing in oral thin films. The result is a platform capable of re-engineering billion-dollar drugs into patient friendly formats.
Merck's MS drug brought in more than $1 billion last year. Its protection ends soon.
This penny stock holds patents into the 2040s. Autoimmune disease is a $28 billion market. Diabetes and obesity could hit $130 billion by 2030. Cancer care is already north of $200 billion annually.
While peers with one program trade at hundreds of millions, this team sits at a fraction of that. Multiple programs. Multiple billion-dollar markets. And a news pipeline that could deliver weekly catalysts.
This is why it is positioned as our number one penny stock biotech alert.
Get our full report today and unlock the name, the symbol, and the complete analysis.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities. |
|
| | | This is a PAID ADVERTISEMENT provided to subscribers of TechStockInsider.Co. Although we have sent you this email, TechStockInsider.Co does NOT specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. | |
|
|
|
|
